- Home
- The American Journal of Tropical Medicine and Hygiene
- Previous Issues
- Volume 85, Issue 6, December 2011
The American Journal of Tropical Medicine and Hygiene - Volume 85, Issue 6, December 2011
Volume 85, Issue 6, December 2011
- Images in Clinical Tropical Medicine
- Perspective
-
-
Adaptive Trial Design: Could We Use This Approach to Improve Clinical Trials in the Field of Global Health?
Pages: 967–970More LessAbstract.We need more clinical trials in the world's poorest regions to evaluate new drugs and vaccines, and also to find better ways to manage health issues. Clinical trials are expensive, time consuming, and cumbersome. However, in wealthier regions these limiting factors are being addressed to make trials less administrative and improve the designs. A good example is adaptive trial design. This innovation is becoming accepted by the regulators and has been taken up by the pharmaceutical industry to reduce product development times and costs. If this approach makes trials easier and less expensive surely we should be implementing this approach in the field of tropical medicine and international health? As yet this has rarely been proposed and there are few examples. There is a need for raising the awareness of these design approaches because they could be used to make dramatic improvements to clinical research in developing countries.
- Top
-
- Articles
-
-
Nurturing the Global Workforce in Clinical Research: The National Institutes of Health Fogarty International Clinical Scholars and Fellows Program
Pages: 971–978More LessAbstract.The Fogarty International Clinical Research Scholars and Fellows Program's goal is to foster the next generation of clinical investigators and to help build international health research partnerships between American and international investigators and institutions. Through June 2012, 61 sites in 27 countries have hosted 436 Scholars (American students or junior trainees from the host countries) and/or 122 Fellows (American and host country postdoctoral fellows) for year-long experiences in global health research. Initially, the program was oriented toward infectious diseases, but recently emphasis on chronic disease research has increased. At least 521 manuscripts have been published, many in high-impact journals. Projects have included clinical trials, observational studies, translational research, clinical-laboratory interface initiatives, and behavioral research. Strengths of the program include training opportunities for American and developing country scientists in well-established international clinical research settings, and mentorship from experienced global health experts.
-
Prevalence of Single Nucleotide Polymorphisms in the Plasmodium falciparum Multidrug Resistance Gene (Pfmdr-1) in Korogwe District in Tanzania Before and After Introduction of Artemisinin-Based Combination Therapy
Pages: 979–983More LessAbstract.Tanzania implemented artemether-lumefantrine (AL) as the first-line treatment for uncomplicated malaria in November of 2006 because of resistance to sulfadoxine-pyrimethamine. AL remains highly efficacious, but widespread use may soon facilitate emergence of artemisinin tolerance/resistance, which initially may be detected at the molecular level as temporal changes in the frequency of single nucleotide polymorphisms (SNPs) in the Pfmdr-1 gene associated with AL resistance. In Tanzania, 830 Plasmodium falciparum-positive samples collected between 2003 and 2010 were examined for SNPs of Pfmdr-1 at codons 86, 184, and 1246. Both the N86 and 184F increased from 2006 to 2010 (logistic regression; N86: odds ratio [95% confidence interval] = 1.35 [1.07–1.71], P = 0.01; 184F: odds ratio = 1.42 [1.07–1.88], P = 0.02), and no change was found for D1246 (odds ratio = 1.01 [0.80–1.28], P = 0.9). The observed changes may be because of introduction of AL, and if so, this finding gives cause for concern and argues for continued surveillance of these molecular markers.
-
Inhibitory Activity of Ferroquine, versus Chloroquine, against Western Kenya Plasmodium falciparum Field Isolates Determined by a SYBR Green I In Vitro Assay
Pages: 984–988More LessAbstract.Ferroquine (FQ), a chloroquine (CQ) analog, is being developed to treat persons with Plasmodium falciparum malaria. In 146 P. falciparum field isolates from western Kenya, we measured 50% inhibitory concentrations (IC50; nM) of CQ and FQ by a SYBR Green I in vitro assay. Reference clones included W2 (CQ resistant) and D6 (CQ sensitive). Mutation analysis was done for P. falciparum CQ-resistance transporter gene (Pfcrt K76T). Median IC50 values for FQ were lower than CQ for field isolates and the W2 clone (both P < 0.05). The Pfcrt mutation (76T), which was detected in > 80% of isolates, conferred higher CQ IC50 values (P < 0.05) and modestly lower FQ IC50 values (P < 0.05), versus Pfcrt wild type (K76). FQ is more potent than CQ against CQ-resistant P. falciparum field isolates and the W2 clone, and is less affected by Pfcrt 76T. These findings support the notion that FQ could be useful in treating persons with P. falciparum malaria.
-
Development and Evaluation of a Rapid Diagnostic Test for Plasmodium falciparum, P. vivax, and Mixed-Species Malaria Antigens
Pages: 989–993More LessAbstract.Plasmodium falciparum and P. vivax malaria are endemic to many parts of the world and humans can be co-infected with both species. Because each Plasmodium species has different biological and clinical characteristics, accurate differentiation of the infecting species is essential for effective treatment. Therefore, we produced three monoclonal antibodies that recognize the lactate dehydrogenase of P. falciparum, P. vivax, or both to develop the first P. falciparum, P. vivax, and mixed-species infections malaria antigen detection kit. The detection limits of this kit were 150 and 250 parasites/μL for P. falciparum and P. vivax, respectively, and the kit was able to detect mixed-species infections. The sensitivity and specificity of this kit was assessed with 722 clinical specimens. Our results showed that its sensitivities for P. falciparum, P. vivax, and mixed-species infection were 96.5%, 95.3%, and 85.7%, respectively. In addition, its specificity was high (99.4%).
-
Analysis of Polymorphisms in the Merozoite Surface Protein-3α Gene and Two Microsatellite Loci in Sri Lankan Plasmodium vivax: Evidence of Population Substructure in Sri Lanka
Pages: 994–1001More LessAbstract.The geographical distribution of genetic variation in Plasmodium vivax samples (N = 386) from nine districts across Sri Lanka is described using three markers; the P. vivax merozoite surface protein-3α (Pvmsp-3α) gene, and the two microsatellites m1501 and m3502. At Pvmsp-3α, 11 alleles were found with an expected heterozygosity (He) of 0.81, whereas at m1501 and m3502, 24 alleles (He = 0.85) and 8 alleles (He = 0.74) were detected, respectively. Overall, 95 unique three locus genotypes were detected among the 279 samples positive at all three loci (He = 0.95). Calculating the pairwise fixation index (F ST) revealed statistically significant population structure. The presence of identical 2-loci microsatellite genotypes in a significant proportion of samples revealed local clusters of closely related isolates contributing to strong linkage disequilibrium between marker alleles. The results show evidence of high genetic diversity and possible population substructure of P. vivax populations in Sri Lanka.
-
Prevalence of Malaria among Patients Attending Public Health Facilities in Maputo City, Mozambique
Pages: 1002–1007More LessAbstract.We conducted a health facility-based survey to estimate the prevalence of malaria among febrile patients at health facilities (HFs) in Maputo City. Patients answered a questionnaire on malaria risk factors and underwent malaria testing. A malaria case was defined as a positive result for malaria by microscopy in a patient with fever or history of fever in the previous 24 hours. Among 706 patients with complete information, 111 (15.7%) cases were identified: 105 were positive for Plasmodium falciparum only, two for Plasmodium ovale only, and four for both P. falciparum and P. ovale. Fever documented at study enrollment, age ≥ 5 years, rural HF, and travel outside Maputo City were statistically significantly associated with malaria by multivariate analysis. We found a high prevalence of laboratory-confirmed malaria among febrile patients in Maputo City. Further studies are needed to relate these findings with mosquito density to better support malaria prevention and control.
-
Peripheral Polyneuropathy and Mefloquine Prophylaxis
Pages: 1008–1009More LessAbstract.We describe a case of a woman who developed a peripheral polyneuropathy shortly after completing 4 weekly doses of mefloquine hydrochloride (250 mg) malaria prophylaxis. Although mefloquine-related central nervous system neuropathy is well described in the literature, peripheral polyneuropathy similar to this case has been documented only once before, to our knowledge.
-
Review: Improving the Therapeutic Index of 8-Aminoquinolines by the Use of Drug Combinations: Review of the Literature and Proposal for Future Investigations
Pages: 1010–1014More LessAbstract.Because 8-aminoquinolines affect critical survival stages of Plasmodium parasites, treatment and control of malaria could be markedly improved by more widespread use of these drugs; however, hemolytic toxicity, which is widely prevalent in G6PD-deficient patients, severely constrains this use. Primaquine was approved more than 50 years ago after extensive clinical testing. Review of the mid-20th century literature in the light of present understanding of pharmacokinetics and metabolism suggests that manipulation of these factors might dissociate 8-aminoquinoline efficacy from toxicity and lead to an improved therapeutic index.
-
Review: Malaria Chemoprophylaxis for Travelers to Latin America
Pages: 1015–1024More LessAbstract.Because of recent declining malaria transmission in Latin America, some authorities have recommended against chemoprophylaxis for most travelers to this region. However, the predominant parasite species in Latin America, Plasmodium vivax, can form hypnozoites sequestered in the liver, causing malaria relapses. Additionally, new evidence shows the potential severity of vivax infections, warranting continued consideration of prophylaxis for travel to Latin America. Individualized travel risk assessments are recommended and should consider travel locations, type, length, and season, as well as probability of itinerary changes. Travel recommendations might include no precautions, mosquito avoidance only, or mosquito avoidance and chemoprophylaxis. There are a range of good options for chemoprophylaxis in Latin America, including atovaquone-proguanil, doxycycline, mefloquine, and—in selected areas—chloroquine. Primaquine should be strongly considered for nonpregnant, G6PD-nondeficient patients traveling to vivax-endemic areas of Latin America, and it has the added benefit of being the only drug to protect against malaria relapses.
-
Characterization of Novel Leishmania infantum Recombinant Proteins Encoded by Genes from Five Families with Distinct Capacities for Serodiagnosis of Canine and Human Visceral Leishmaniasis
Geraldo G. S. Oliveira, Franklin B. Magalhães, Márcia C. A. Teixeira, Andrea M. Pereira, Cristiane G. M. Pinheiro, Lenita R. Santos, Marília B. Nascimento, Cheila N. G. Bedor, Alessandra L. Albuquerque, Washington L. C. dos-Santos, Yara M. Gomes, Edson D. Moreira Jr, Maria E. F. Brito, Lain C. Pontes de Carvalho and Osvaldo P. de Melo NetoPages: 1025–1034More LessAbstract.To expand the available panel of recombinant proteins that can be useful for identifying Leishmania-infected dogs and for diagnosing human visceral leishmaniasis (VL), we selected recombinant antigens from L. infantum, cDNA, and genomic libraries by using pools of serum samples from infected dogs and humans. The selected DNA fragments encoded homologs of a cytoplasmic heat-shock protein 70, a kinesin, a polyubiquitin, and two novel hypothetical proteins. Histidine-tagged recombinant proteins were produced after subcloning these DNA fragments and evaluated by using an enzyme-linked immunosorbent assays with panels of canine and human serum samples. The enzyme-linked immunosorbent assays with different recombinant proteins had different sensitivities (67.4–93.0% and 36.4–97.2%) and specificities (76.1–100% and 90.4–97.3%) when tested with serum samples from Leishmania-infected dogs and human patients with VL. Overall, no single recombinant antigen was sufficient to serodiagnosis all canine or human VL cases.
-
Acute Renal Injury as a Result of Liposomal Amphotericin B Treatment in Sodium Stibogluconate Unresponsive Visceral Leishmaniasis
Pages: 1035–1037More LessAbstract.We report an unusual case of visceral leishmaniasis occurring in a patient from Sichuan China. The patient presented with a remitting fever, anemia, and pancytopenia. The case was confirmed as visceral leishmaniasis by microscopical detection of the Leishmania species amastigote in bone marrow aspirate. The patient was treated with 10 mg/kg/day of sodium stibogluconate for 5 days, with no therapeutic response. As a result, the patient was treated with liposomal amphotericin B (LAB) at 10 mg/day as an initial dosage. After treatment with an increasing drug dosage for 7 days, acute renal injury was evident as indicated by increased serum creatinine and urea nitrogen. LAB administration was discontinued until serum creatinine and serum urea nitrogen regressed on Day 15. Two maintenance treatments of 100 mg/day LAB were given on Days 19 and 26 (total 870 mg, 14.5 mg/kg). Bone marrow aspirate and clinical examination suggested total remission.
-
Amebiasis-Related Mortality among United States Residents, 1990–2007
Pages: 1038–1040More LessAbstract.Despite the endemic nature of Entamoeba histolytica infection in the United States there is a lack of data on amebiasis-related mortality. We analyzed national death certificate data from 1990 to 2007 to assess the occurrence of amebiasis-related deaths and determine demographic and regional associations. A total of 134 deaths were identified. Mortality rates were highest in males, Hispanics, Asian/Pacific Islanders, and persons 75 years of age and older. An association with human immunodeficiency virus infection was also observed. A declining trend of amebiasis deaths was noted over the 18-year study period. Over 40% of fatal amebiasis cases occurred in residents of California and Texas. United States-born persons accounted for the majority of amebiasis deaths; however, all of the fatalities in Asian/Pacific Islanders and 60% of the deaths in Hispanics were in foreign-born individuals. Although uncommon, amebiasis-related deaths routinely occur in the United States.
-
Seventeen Years of Annual Distribution of Ivermectin Has Not Interrupted Onchocerciasis Transmission in North Region, Cameroon
Pages: 1041–1049More LessAbstract.We studied onchocerciasis transmission and impact on ocular morbidity in three health districts in North Region, Cameroon, where annual mass ivermectin treatment has been provided for 12–17 years. The studies, which took place from 2008 to 2010, consisted of skin snips for microfilariae (mf), palpation examinations for nodules, slit lamp examinations for mf in the eye, and Simulium vector dissections for larval infection rates. Adults had mf and nodule rates of 4.8% and 13.5%, respectively, and 5.5% had mf in the anterior chamber of the eye. Strong evidence of ongoing transmission was found in one health district, where despite 17 years of annual treatments, the annual transmission potential was 543 L3/person per year; additionally, children under 10 years of age had a 2.6% mf prevalence. Halting ivermectin treatments in North Cameroon now might risk recrudescence of transmission and ocular disease.
-
Molecular Characterization of Blastocystis Obtained from Members of the Indigenous Tapirapé Ethnic Group from the Brazilian Amazon Region, Brazil
Pages: 1050–1053More LessAbstract.A total of 382 stool samples were examined during a survey of intestinal parasites in members of the Tapirapé ethnic group, who live in the Brazilian Amazon region of Mato Grosso. Fecal DNAs from Blastocystis-positive samples were extracted, polymerase chain reaction amplified using Blastocystis-specific primers targeting the small subunit rRNA gene, and sequenced. Three subtypes (STs) were identified: ST1 (41%), ST2 (32%), and ST3 (17%). Seven mixed infections were found (11%). The subtype distribution was markedly different from that reported in Europe in that ST4 was not detected and ST3 was not the most common subtype. This study is the first to include molecular characterization of Blastocystis in Brazil and in indigenous communities from Latin America.
-
Evaluation of an IgY-Based Immunomagnetic Enzyme-Linked Immunosorbent Assay System for Detection of Circulating Schistosoma japonicum Antigen in Serum Samples from Patients in China
Pages: 1054–1059More LessAbstract.We have developed a novel egg yolk antibody (IgY)–coated magnetic beads antigen-capture immunoassay for detection of a circulating antigen of Schistosoma japonicum in serum samples of patients in schistosomiasis-endemic areas of China. This IgY-based immunomagnetic bead enzyme-linked immunosorbent assay (IgY-IMB-ELISA) uses polyclonal IgY-coated magnetic beads as a capture antibody, and a monoclonal IgG as a detection antibody. The sensitivity of the magnetic immunoassay was 100% (40 of 40) in cases of acute infection and 91.5% (107 of 117) in chronic cases of schistosomiasis, and no positive reaction was found in 0 of 49 healthy persons. Cross-reactivity was 3.3% (1 of 33) with clonorchiasis and 0% (0 of 20) with paragonimiasis. There was a significant correlation between ELISA absorbance value and egg count (eggs per gram feces) and a correlation coefficient of 0.88 in a small sample of 14 patients. The results demonstrated that the IgY-IMB-ELISA is a sensitive and specific assay for detection of human schistosomiasis japonica.
-
HIV Target Cells in Schistosoma haematobium-Infected Female Genital Mucosa
Pages: 1060–1064More LessAbstract.The parasite Schistosoma haematobium frequently causes genital lesions in women and could increase the risk of human immunodeficiency virus (HIV) transmission. This study quantifies the HIV target cells in schistosome-infected female genital mucosa. Cervicovaginal biopsies with and without schistosomiasis were immunostained for quantification of CD4+ T lymphocytes (CD3, CD8), macrophages (CD68), and dendritic Langerhans cells (S100 protein). We found significantly higher densities of genital mucosal CD4+ T lymphocytes and macrophages surrounding schistosome ova compared with cervicovaginal mucosa without ova (P = 0.034 and P = 0.018, respectively). We found no increased density of Langerhans cells (P = 0.25). This study indicates that S. haematobium may significantly increase the density of HIV target cells (CD4+ T lymphocytes and macrophages) in the female genitals, creating a beneficial setting for HIV transmission. Further studies are needed to confirm these findings and to evaluate the effect of anti-schistosomal treatment on female genital schistosomiasis.
-
Impact of Drought on the Spatial Pattern of Transmission of Schistosoma haematobium in Coastal Kenya
Pages: 1065–1070More LessAbstract.We analyzed temporal changes in spatial patterns of active Schistosoma haematobium infection in different age groups and associated them with ponds infested with Bulinus snails. A major drought between 2001 and 2009 resulted in drying of ponds that were known sources of infection, and we detected very few or no snails in ponds that were infested in the past. The household-level spatial pattern of infection for children of various age groups in 2009 was contrasted with historical data from 2000. The significant local clustering of high- and low-infection levels among school-aged children that occurred in 2000 was absent in 2009. We attribute the disappearance of significant clustering around historical transmission hot spots to a decade-long drought in our study area. The implications of extreme weather and climate conditions on risk and transmission of S. haematobium and their relevance to control strategies are discussed.
-
Learning Curve of Vesico-Urinary Ultrasonography in Schistosoma haematobium Infection with WHO Practical Guide: A “Simple to Learn” Examination
Pages: 1071–1074More LessAbstract.In developing countries, it is difficult to rally a radiologist to conduct field studies. Here, we report how a radiologist taught a clinician to carry out the ultrasound examination as defined by the World Health Organization (WHO) record sheet for Schistosoma haematobium related lesions. In a population infected with S. haematobium, the learner and teacher performed two ultrasound exams and the results were compared. One hundred thirty-two children were prospectively included, during 8 ultrasonography sessions split over 23 days. After 51 examinations the learner's sensitivity was above 90%. After the fifth session the specificity reached 100% (results remained stable until the end of the study period). This study shows that a clinician can quickly learn how to carry out a simple ultrasound examination to gather the items needed for the follow-up of S. haematobium related lesions, suggesting that clinicians could implement networks of ultrasound-based surveillance on the field.
-
Volumes & issues
-
Volume 104 (2021)
-
Volume 103 (2020)
-
Volume 102 (2020)
-
Volume 101 (2019)
-
Volume 100 (2019)
-
Volume 99 (2018)
-
Volume 98 (2018)
-
Volume 97 (2017)
-
Volume 96 (2017)
-
Volume 95 ([2016, 2017])
-
Volume 94 (2016)
-
Volume 93 (2015)
-
Volume 92 (2015)
-
Volume 91 (2014)
-
Volume 90 (2014)
-
Volume 89 (2013)
-
Volume 88 (2013)
-
Volume 87 (2012)
-
Volume 86 (2012)
-
Volume 85 (2011)
-
Volume 84 (2011)
-
Volume 83 (2010)
-
Volume 82 (2010)
-
Volume 81 (2009)
-
Volume 80 (2009)
-
Volume 79 (2008)
-
Volume 78 (2008)
-
Volume 77 (2007)
-
Volume 76 (2007)
-
Volume 75 (2006)
-
Volume 74 (2006)
-
Volume 73 (2005)
-
Volume 72 (2005)
-
Volume 71 (2004)
-
Volume 70 (2004)
-
Volume 69 (2003)
-
Volume 68 (2003)
-
Volume 67 (2002)
-
Volume 66 (2002)
-
Volume 65 (2001)
-
Volume 64 (2001)
-
Volume 63 (2000)
-
Volume 62 (2000)
-
Volume 61 (1999)
-
Volume 60 (1999)
-
Volume 59 (1998)
-
Volume 58 (1998)
-
Volume 57 (1997)
-
Volume 56 (1997)
-
Volume 55 (1996)
-
Volume 54 (1996)
-
Volume 53 (1995)
-
Volume 52 (1995)
-
Volume 51 (1994)
-
Volume 50 (1994)
-
Volume 49 (1993)
-
Volume 48 (1993)
-
Volume 47 (1992)
-
Volume 46 (1992)
-
Volume 45 (1991)
-
Volume 44 (1991)
-
Volume 43 (1990)
-
Volume 42 (1990)
-
Volume 41 (1989)
-
Volume 40 (1989)
-
Volume 39 (1988)
-
Volume 38 (1988)
-
Volume 37 (1987)
-
Volume 36 (1987)
-
Volume 35 (1986)
-
Volume 34 (1985)
-
Volume 33 (1984)
-
Volume 32 (1983)
-
Volume 31 (1982)
-
Volume 30 (1981)
-
Volume 29 (1980)
-
Volume 28 (1979)
-
Volume 27 (1978)
-
Volume 26 (1977)
-
Volume 25 (1976)
-
Volume 24 (1975)
-
Volume 23 (1974)
-
Volume 22 (1973)
-
Volume 21 (1972)
-
Volume 20 (1971)
-
Volume 19 (1970)
-
Volume 18 (1969)
-
Volume 17 (1968)
-
Volume 16 (1967)
-
Volume 15 (1966)
-
Volume 14 (1965)
-
Volume 13 (1964)
-
Volume 12 (1963)
-
Volume 11 (1962)
-
Volume 10 (1961)
-
Volume 9 (1960)
-
Volume 8 (1959)
-
Volume 7 (1958)
-
Volume 6 (1957)
-
Volume 5 (1956)
-
Volume 4 (1955)
-
Volume 3 (1954)
-
Volume 2 (1953)
-
Volume 1 (1952)
-
Volume s1-31 (1951)
-
Volume s1-30 (1950)
-
Volume s1-29 (1949)
-
Volume s1-28 (1948)
-
Volume s1-27 (1947)
-
Volume s1-26 (1946)
-
Volume s1-25 (1945)
-
Volume s1-24 (1944)
-
Volume s1-23 (1943)
-
Volume s1-22 (1942)
-
Volume s1-21 (1941)
-
Volume s1-20 (1940)
-
Volume s1-19 (1939)
-
Volume s1-18 (1938)
-
Volume s1-17 (1937)
-
Volume s1-16 (1936)
-
Volume s1-15 (1935)
-
Volume s1-14 (1934)
-
Volume s1-13 (1933)
-
Volume s1-12 (1932)
-
Volume s1-11 (1931)
-
Volume s1-10 (1930)
-
Volume s1-9 (1929)
-
Volume s1-8 (1928)
-
Volume s1-7 (1927)
-
Volume s1-6 (1926)
-
Volume s1-5 (1925)
-
Volume s1-4 (1924)
-
Volume s1-3 (1923)
-
Volume s1-2 (1922)
-
Volume s1-1 (1921)